Jose Nazari is a Cardiology physician affiliated with Endeavor Health. OpenAlex indexes 66 publications with 687 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2150 Pfingsten Rd Ste 1200
Glenview, IL 60026
Telephone
847-657-1819Provider last certified this registry record 22 Jan 2021.
Industry payments
31 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202518 payments
- Biosense Webster, Inc.Program year202514 payments
- Novartis Pharmaceuticals CorporationProgram year202523 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
45.9%Antiarrhythmic25.1%Flecainide Acetate40%Amiodarone Hcl33%Dofetilide20%Multaq7%Part D<11 patientsBeta blocker17%Metoprolol Succinate79%Metoprolol Tartrate16%Carvedilol6%Part D<11 patients+ 2 more classes in this area
Blood & clotting
45.4%Factor Xa inhibitor41.3%Eliquis72%Xarelto29%Part D≥91 patientsP2Y12 inhibitor3.3%Clopidogrel100%Part D≥25 patients+ 1 more class in this area
Metabolism & gastrointestinal
6.1%Proton pump inhibitor6.1%Omeprazole100%Part D≥67 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients
Journal of the American College of Cardiology
2025 - Immediate Leg Mobilization is Feasible After Catheter Ablation of Atrial Fibrillation Using Large Vascular Access Sheaths (Pulsed Field and Cryoballoon Ablation)
Journal of Cardiovascular Electrophysiology
2025 - Feasibility of deep sedation for catheter ablation of atrial fibrillation using pulsed field ablation
Journal of Interventional Cardiac Electrophysiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Eisha Wali, MD
Endeavor Health
Amin Kassam, MD
Endeavor Health
Joseph Caprini, MD
Endeavor Health
Peter Sand, MD
Endeavor Health
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”